l-carnitine in the treatment of type ii diabetes effects supplementation on lipid profiles adults: A systematic review and dose-response meta-analysis L-Carnitine​ - Jesdit Infusion

Findings We screened 152 and enrolled 72 patients suffering from advanced pancreatic cancer in a prospective, multi-centre, placebo-controlled, randomized and double-blinded trial to receive oral L-Carnitine (4 g) or placebo for 12 weeks

, ,

L-Arginine(3c361), L-Alanine, L-Proline, L-Ornithine HCL, L-Valine, Choline Bitartrate, Vitamin D3 (Cholecalciferol 100,000 iu), Citrus Bioflavonoids, Vitamin C (Ascorbic), L-Methionine(3c305), Vitamin E (Natural dl-a-Tocopheryl Acetate 700iu), Iron Ferrous Fumerate, L-Carnitine, L-Tyrosine, N-Acetyl-L-Cysteine HCL, Zinc Sulphate Monohydrate, Manganese Gluconate, L-Glutamic Acid, Vitamin A Retinol Acetate 325,000iu/g, Vitamin B12 (Cyonacobalamin), Vitamin B3 (Niacinamide Crystalline), Vitamin B5 (D-Calcium Pantothenate), Vitamin B6 (Pyridoxine HCL), Biotin (3a880)

They recommend monitoring carnitine levels and metabolic function, and considering supplementation only if deficiencies are identified or if clinical signs suggest a need